Derivation Web

source_f9c97d716c7d473c

**Selected angle:** `source`

## One-sentence thesis

Across 5 independently cited sources, the evidence converges on one bounded claim: sGLT2 inhibitors reduce the risk of cardiovascular and cardiorenal composite outcomes and heart failure events in patients with cardiovascular disease, heart failure, or chronic kidney disease. Effect sizes vary by subgroup and are listed per source below rather …